Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy
about
Non-steroid agents for idiopathic pulmonary fibrosisImmunomodulatory agents for idiopathic pulmonary fibrosisCD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosisInfluence of cigarette smoking on bronchoalveolar lavage cellularity in asbestos-induced lung diseaseLipoprotein macroaggregates in bronchoalveolar lavage fluid from patients with diffuse interstitial lung disease: comparison with idiopathic alveolar lipoproteinosisInterstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up.New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitisIncreased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosisEosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract.Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis.Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.Idiopathic pulmonary fibrosis: current and future treatment options.Lung inflammation and fibrosis: an alveolar macrophage-centered perspective from the 1970s to 1980s.Interstitial lung disease and asthma in hard-metal workers: bronchoalveolar lavage, ultrastructural, and analytical findings and results of bronchial provocation tests.Chronic pulmonary sarcoidosis: relationship between lung lavage cell counts, chest radiograph, and results of standard lung function tests.Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management?Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitisPulmonary gamma interferon production in patients with fibrosing alveolitis.Evidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosisComputed tomography-guided bronchoalveolar lavage in idiopathic pulmonary fibrosis.Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis.Idiopathic eosinophilic pneumonia in children: the French experience.The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.Eosinophilic pneumonias in children: A review of the epidemiology, diagnosis, and treatment.The many uses of bronchoalveolar lavage.Assessment of progression of asbestosis in the sheep model by bronchoalveolar lavage and pulmonary function tests.Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats.Bronchoalveolar neutrophilia inversely correlates with DLCO at diagnosis in asbestosis but not lung function decline at 1 year.The advantages and limitations of an in vivo test system for investigating the cytotoxicity and fibrogenicity of fibrous dusts.The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis.Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.Identification of inorganic dust particles in bronchoalveolar lavage macrophages by energy dispersive x-ray microanalysis.Inhaled lead affects lung pathology and inflammation in sensitized and control guinea pigs.Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components.
P2860
Q24235478-0B53B746-8F25-4989-BA21-87D29D152ABCQ24248714-3F1ED00C-0EB4-4F4C-8FAE-A636B126E4E8Q24811707-AB382915-D8E1-4F8C-81A3-66D835F21618Q26341878-15A70C43-9206-450C-BC72-05A67EE9BF5FQ33603988-380E12AC-5F5F-4E35-95F3-27F98D76BAA7Q33604601-3A6B4F1D-6475-416E-8E69-9FAF6D02AD7FQ33604630-B47F7D8D-8F49-4C3C-9DE6-42DDA07D2702Q34213002-FC02219F-EDDF-4594-848B-D97B8A650305Q34612311-94BF1353-0A31-48C8-9A92-E0B86993DF36Q35325160-D29E20B2-0051-4CB8-977C-8A620023D505Q35535709-FA7529B3-EBFF-47DB-B5FC-039566966A51Q35627863-177F366E-65F1-468E-9E08-0879E9A43716Q35959091-F4BF27F5-8262-4CC5-BCA0-8982D24DCBE7Q36126500-3A78DE89-563C-4DBE-BA67-19549327229CQ36147200-9CC9ADF4-2E52-4F3A-8245-79C04D630398Q36160908-C4B23E54-95DB-4C42-985B-512993C0F292Q36199377-7B42C952-16AF-4068-A564-64C11104D090Q36215192-1B7B7B82-3B97-4AA2-903E-A1560278D5ECQ36225851-B398A3C8-016A-4F9E-BD53-5CBC169C012CQ36498918-233AA702-279D-4356-9704-88D5435595C4Q36570301-DCF7C01F-60F8-47DB-84F4-42A6711375F9Q37608220-D3A851C6-5252-4B63-BC3C-FE27FE207111Q38290539-2AF4C371-BBCA-451E-8E67-1DE3B3532ED9Q38682850-4FB1933D-7CBA-412A-B888-F04E4EC6A15DQ39604764-486A3142-6343-44A3-A23F-2F56E194ECB0Q41120154-AB39229C-053F-49A8-80EC-E6779DCCFF71Q41127857-4D64DA82-A484-4C37-B2EF-928B4A41DB42Q41375161-3F8D89C2-ED2A-4147-89FF-37B7DFA59087Q42114210-539CEB64-C140-4276-99F0-D88F3B2BBAC4Q42607851-32EA2989-A1C9-4479-BF72-50B0A7B01D7CQ42635812-5282D784-EB92-4B98-8F8A-2A36159FC86FQ44427896-FFC80BD9-64DD-450F-99CC-21BAD20BE4B7Q45291637-A788E03D-CBB7-49A2-94F7-66DF6328F64BQ48020777-AEEDC502-2274-47FC-8F3D-F16E7425A6F6
P2860
Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Bronchoalveolar lavage fluid c ...... and their relation to therapy
@ast
Bronchoalveolar lavage fluid c ...... and their relation to therapy
@en
type
label
Bronchoalveolar lavage fluid c ...... and their relation to therapy
@ast
Bronchoalveolar lavage fluid c ...... and their relation to therapy
@en
prefLabel
Bronchoalveolar lavage fluid c ...... and their relation to therapy
@ast
Bronchoalveolar lavage fluid c ...... and their relation to therapy
@en
P2093
P2860
P356
P1433
P1476
Bronchoalveolar lavage fluid c ...... and their relation to therapy
@en
P2093
Collins JV
Lukoszek A
Salsbury AJ
Turner-Warwick M
P2860
P304
P356
10.1136/THX.35.5.328
P407
P577
1980-05-01T00:00:00Z